Exchange: NYSE·Updated 12:34 AM EDT
NVO logo

NVO Novo Nordisk A/S

$47.40
$0.11
(0.23%)
Overnight
Prev Close $47.51
EarningsNov 4
Mkt Cap$158.96B
Vol8.77M

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
41

Bearish Sentiment

How do you feel about NVO?

Advertisement|Remove ads.